Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventional
Not Applicable
Recruiting
- Conditions
- Chronic Heart Failure, Chronic Renal Failure
- Registration Number
- JPRN-UMIN000008712
- Lead Sponsor
- Division of Kidney and Hypertension, the Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)The patients showing allergy to tolvaptan or similar compound (ex. mozavaptan) 2)The patients showing allergy to sulfonamide 3)The anuric patients 4)The patients without a sense of thirst or ability to intake water 5)The patients with hypernatremia 6)The pregnant patients 7)The patients taking tolvaptan at the time of enrolling 8)The patitents in need of emergency medical care for massive heart failure 9)The patients given furosemide over 120mg/day at the time of enrolling 10)The patients with hepatic coma 11)The patients regarded as inappropriate for this clinical study by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method